Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 60% · prior close shown (market closed)
INOVIO PHARMACEUTICALS, INC. shows stable business momentum based on AlphaOS pipeline evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 4d ago
INO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on INO.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for INOVIO PHARMACEUTICALS, INC. (INO) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
INO's AI investment thesis
Upgrade to Premium for INO's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$1.21
Market cap
$125.11M
Profitable
No
Revenue $65,343.00
Net income
$-84.95M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for INOVIO PHARMACEUTICALS, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow INOVIO PHARMACEUTICALS, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.